Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Instil Bio, Inc.
(NQ:
TIL
)
13.25
-0.30 (-2.21%)
Streaming Delayed Price
Updated: 11:27 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Instil Bio, Inc.
< Previous
1
2
3
Next >
TIL Stock Earnings: Instil Bio Beats EPS for Q2 2024
August 13, 2024
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
August 03, 2024
Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million,...
Via
Talk Markets
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 12, 2024
Via
Benzinga
TIL Stock Earnings: Instil Bio Beats EPS for Q4 2023
March 21, 2024
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
TIL Stock Earnings: Instil Bio Beats EPS for Q2 2023
December 13, 2023
TIL stock results show that Instil Bio beat analyst estimates for earnings per share the second quarter of 2023.
Via
InvestorPlace
Instil Bio Resumes ITIL-306 Study In Lung, Ovarian, Renal Cancers
January 09, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Instil Bio
December 12, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 12, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via
InvestorPlace
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2024
May 10, 2024
TIL stock results show that Instil Bio missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2023
December 13, 2023
TIL stock results show that Instil Bio missed analyst estimates for earnings per share the first quarter of 2023.
Via
InvestorPlace
TIL Stock Earnings: Instil Bio Misses EPS for Q3 2023
December 13, 2023
TIL stock results show that Instil Bio missed analyst estimates for earnings per share the third quarter of 2023.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
June 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 29, 2022
Via
Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
December 28, 2022
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 15, 2022
On Thursday, 241 companies hit new 52-week lows.
Via
Benzinga
Instil Bio Discontinues ITIL-168 Cancer Trials, Layoffs 60% Of Its Employees
December 08, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
6 Analysts Have This to Say About Instil Bio
November 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
On Wednesday, 115 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Monday saw 196 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 09, 2022
On Friday, 127 companies set new 52-week lows.
Via
Benzinga
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
December 08, 2022
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 08, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 06, 2022
Tuesday's session saw 167 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 08, 2022
During Thursday's trading, 138 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 22, 2022
During Tuesday's trading, 160 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 18, 2022
On Friday, 64 companies achieved new lows for the year.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.